Navigation Links


biologics at medicine technology

Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkin's Lymphoma

...ded. Biovest has a foundation in themanufacture of biologics for research and clinical trials. Inaddition, Biovest develops, manufactures and markets patented cellculture systems, including the innovative AutovaxID(TM), which isbeing marketed as an automated vaccine manufacturing instrument andfor production o...

Expert Opinion Highlights Avigen's AV411 as Potential New Therapeutic for Neuropathic Pain and Opioid Withdrawal

...y focused on unique smallmolecule therapeutics and biologics to treat serious neurologicaldisorders, including ...eutical company committed to its smallmolecule and biologics neurology products. The company currentlyhas in development AV650 for neuromuscular spasm and spasti...

Clinical Update - Debio 9902 (ZT-1) for Alzheimer's Disease

...l developmentspecialist that in-licenses promising biologics and small moleculedrug candidates. Debiopharm develops its products for globalregistration and maximum commercial potential for out-licensing topharmaceutical partners for sales and marketing. Debiopharm independently funds the worldwide development...

Extensive Clinical Data on Erbitux Presented at the 2007 ASCO Annual Meeting

...ionalcombinations of ERBITUX with chemotherapy and biologics in patientswith this aggressive cancer for whom treatment options remainacutely limited. Other ERBITUX data presented at ASCO included the following: -- Two randomized studies evaluated ERBITUX combined withoxaliplatin-based chemotherapy in first l...

Positive Final Data from HyCAMP Phase II Trial in Metastatic Colorectal

... and enhance the retention of anti-cancerdrugs and biologics within tumours. The drug becomes entrainedwithin the HA matrix and the HA binds to receptors located on thetumour cell resulting in more of the drug being delivered to thetumour. Preclinically, the HyACT(TM) technology has demonstratedimproved delive...

Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for the Treatment of Psoriasis

...oriasis. Consequently, recently approvedanti-TNF-? biologics have proven effective; however, they have tobe administered frequently and at high doses and are thereforeassociated with substantial manufacturing costs and inconveniencefor patients. CYT007-TNFQb is a therapeutic vaccine in development for thetrea...

VGX Pharmaceuticals' Novel HIV and Pandemic Influenza DNA Vaccine Candidates Trigger Robust Immune Responses and Protection in Pre-Clinical Models

... biopharmaceutical company with smallmolecules and biologics product candidates for the treatment ofinfectious diseases, cancer and inflammatory diseases. TheCompany's clinical development programs include PICTOVIR(TM) forHIV infection and VGX-410C for chronic HCV infection, both of whichare currently in Phase...

Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free Survival by 45 Percent in Patients With Intermediate-Risk Kidney Cancer

...determine whether there is anopportunity to file a biologics license application (BLA) on thebasis of these results along with appropriate commitments toconduct further clinical investigations to support the efficacy ofOncophage in renal cell carcinoma. Antigenics also plans to explorethe need for further clin...

Dendreon Announces Presentation of Data at American Urological Association Annual Meeting

... aclinical trial for PROVENGE will not support our biologics licenseapplication, the risk that the FDA may interpret data differentlythan we do or require more data or a more rigorous analysis of datathan expected, the risk that the FDA will not approve a biologicslicense application for a therapeutic, the ris...

Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment of HCV

...l developmentspecialist that in-licenses promising biologics and small moleculedrug candidates. Debiopharm develops its products for globalregistration and maximum commercial potential for out-licensing topharmaceutical partners for sales and marketing. Debiopharm independently funds the worldwide development...

Preclinical Update - Debio-0512 Therapeutic Vaccine for the Treatment of Chronic and Acute Inflammatory Conditions

...ical developmentcompany that in-licenses promising biologics and small moleculedrug candidates. Debiopharm develops its products for globalregistration and maximum commercial potential for out-licensing topharmaceutical partners for sales and marketing. Debiopharm independently funds the worldwide development...
Other Contentscarnivorecarnivorefixationfixationfixationfixationfixationfixationfixationfixationcarboncarboncarboncarboncarboncarboncarboncarriercarriercarriercarriercarriercarriercarriercarriercarriercartilagecartilagecartilagecartilagecartilagecartilagecartilagedivisiondivisiondivisiondivisiondivisiondivisiondivisionanabolismanabolismnucleusnucleusnucleusnucleusnucleusnucleusnucleusnucleusnucleus
(Date:7/23/2008)...io Wealthy nations willing to collectively spend ...on of roughly half a billion metric tons of carbon...rch suggests. , It would take about that much m...restation in the world, one of the top contributor...e. , If adopted, this type of program could have...
(Date:7/23/2008)...d summit" will bring together internationally reno....S., Russia, China, Japan, Australia and India to... to Aug. 2. , "We are bringing together the w...e," said summit organizer J. William Schopf, found...s and Planetary Physics, Center for the Study of E...
(Date:7/23/2008)...t the National Institute of Standards and Technolo...e formation of clumps of proteins in protein-based...rifies the conditions under which scientists can b...asuring the formation of protein aggregates, a maj...l and safety in biologic drug manufacturing. , P...
(Date:7/23/2008)... scientists who set out to study sex pheromones in...nes also controls a stage in the worms, life cycle...published in Nature online on July 23, represent...e been linked through so-called small molecules. ...eins as the major players in an organism,s biology...
Breaking Biology News(10 mins):Paying to save tropical forests could be a way to reduce global carbon emissions 2Paying to save tropical forests could be a way to reduce global carbon emissions 3Paying to save tropical forests could be a way to reduce global carbon emissions 4UCLA 'world summit' to explore ancient life on Earth, and beyond 2NIST trumps the clumps: Making biologic drugs safer 2Sex and lifespan linked in worms 2Under the Canopy 28R 29 Turns a New Leaf With 2008 Spring Season 13696 1Under the Canopy 28R 29 Turns a New Leaf With 2008 Spring Season 13696 2Medco Tops Fortunes List of Americas Most Admired Companies in its Industry 13692 1Medco Tops Fortunes List of Americas Most Admired Companies in its Industry 13692 2Medco Tops Fortunes List of Americas Most Admired Companies in its Industry 13692 3Biking Walking Best for New Knees 13688 1Biking Walking Best for New Knees 13688 2Biking Walking Best for New Knees 13688 3ProMetic reports continued positive data in PBI 1402 phase II trial in chemotherapy induced anemia 3764 1ProMetic reports continued positive data in PBI 1402 phase II trial in chemotherapy induced anemia 3764 2ProMetic reports continued positive data in PBI 1402 phase II trial in chemotherapy induced anemia 3764 3
(Date:7/25/2008)... to benefit ALS Therapy Alliance to be presented a...ht, WOONSOCKET, R.I., July 25 /PRNewswire/ -- CVS...ised a record-breaking $4.4 million in just 21 day... for ALS research. This is,the seventh year of the...sed more than $15 million for ALS research. This y...
(Date:7/25/2008)...ds fluid back-up in esophagus can cause immune sys...ay News) -- The first evidence linking gastroesoph...scovered by Duke University Medical Center researc...ns was first noted in the 1970s, and since then st...rcent of asthma patients also experience GERD symp...
(Date:7/25/2008)... New program delivers immediate co...[24-hour telephone access to language interpreters...g multilingual solutions. , ...LLE® http://www.lle-inc.com/index.html [(Lan...ider of interpretation, translation, and language ...
(Date:7/25/2008)... Whether you are an Olympian, Prof..., there are Five Things You Need to Know about Hyd....C. Spine and Sports Center , ...-- America,s premier athletes are heading to Beiji...ng and sacrifice in the hopes of capturing an Olym...
Breaking Medicine News(10 mins):Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:People With GERD More Likely to Develop Asthma 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5
Other TagscoastparkparkparkparkparkeacheacheacheacheachboxespregnanciesOther Tagscorticosteroid 2systemic 2systemic 3systemic 4systemic 5systemic 6predispose 2predispose 3predispose 4coli 2coli 3coli 4coli 5investigating 2investigating 3investigating 4investigating 5investigating 6investigating 7investigating 8evade 2evade 3